Recent Updates
Recently added Catalysts
LXRX Positive Sentiment

Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference

Tuesday, May 12, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Lexicon Pharmaceuticals will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference on May 19, 2026. The event will be held at the Nasdaq World Headquarters in New York City. Interested parties can access the live event and its replay through the company's website.
Price reaction · baseline $2.31 (2026-05-11 close) · hit after-hours · clean, no other LXRX news in the window
day 0 close · peak
+4.3%

Market Sentiment Analysis

POSITIVE FACTORS

  • Lexicon Pharmaceuticals is actively engaging with investors.
  • Participation in a prominent investor conference highlights company visibility.
  • The company has a diverse pipeline addressing significant health issues.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus

Full Press Release Details

THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) --Lexicon Pharmaceuticals, Inc.(Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the 4th Annual H.C. Wainwright BioConnect Investor Conference, taking place at the Nasdaq World Headquarters in New York City, on May 19, 2026.
The live event and a replay of the presentation can be accessed via the Events page of the Company’s website athttps://investors.lexpharma.com/.
About Lexicon PharmaceuticalsLexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Lexicon has a pipeline of drug candidates in discovery, preclinical, and clinical development in neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity and metabolic disorders, and other cardiometabolic indications. For additional information, please visitwww.lexpharma.com.

For Media Inquiries:Dave BelianLexicon Pharmaceuticals, Inc.lexinvest@lexpharma.com

For Investor Inquiries:Lisa DeFrancescoLexicon Pharmaceuticals, Inc.lexinvest@lexpharma.com

Frequently Asked Questions

When is Lexicon Pharmaceuticals presenting?

Lexicon Pharmaceuticals will present on May 19, 2026.

Where is the conference taking place?

The conference will be held at the Nasdaq World Headquarters in New York City.

How can I access the presentation?

The live event and replay can be accessed via Lexicon's Events page.

What is Lexicon's focus area?

Lexicon focuses on developing medicines for various health conditions.

ShareAdd on Google
Tags: LXRX Viatris Investor Conferences Healthcare Lexicon Pharmaceuticals H.C. Wainwright BioConnect investor conference
Last updated: May 12, 2026

Biotech snapshot

Cash runway
$191M liquidity · $3M/mo burn
~61 mo
Minimal dilution risk
Lead asset
SotagliflozinPhase 3
Type 1 Diabetes Mellitus →

Catalyst track record

+111%
best trade around LXRX's most recent catalyst

Peak hindsight return over a 120-day window, across 13 tracked FDA/PDUFA catalysts for LXRX.

See every catalyst's timing & PoA →